This workshop co-organized by InSingulo and Dr. Snijder from AstraZeneca will explore the latest advancements in GPCR drug discovery research. Our aim is to bring together renowned international experts from industry, academia and service providers to facilitate communication between scientific groups and research areas within GPCR drug discovery community. Particular focus will be on topics such as affinity screening, biophysical mode of action studies, hit finding and structure based drug discovery. We believe this will eventually lead to uncovering common challenges and finding new innovative approaches to drug discovery for GPCRs.